Intravenous cyclosporine in severe ulcerative colitis: Ready to stand alone?

Gastroenterology

Volumn 120, Issue 6, 2001, Pages 1541-1543

  Cohen, R D ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; MERCAPTOPURINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

COMBINATION CHEMOTHERAPY; CORTICOSTEROID THERAPY; DRUG INDICATION; DRUG POTENTIATION; DRUG SAFETY; EDITORIAL; ELECTROLYTE DISTURBANCE; HUMAN; HYPERTENSION; HYPERTRICHOSIS; IMMUNOSUPPRESSIVE TREATMENT; NEUROTOXICITY; PARESTHESIA; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREMOR; ULCERATIVE COLITIS;

EID: 0035049547     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.24398     Document Type: Article

References (23)

1. Cyclosporin in severe ulcerative colitis refractory to steroid therapy
2. Intravenous cyclosporin in ulcerative colitis: A five-year experience
3. CYA in severe steroid-resistant UC: Long-term results of therapy
4. Predicting outcome in severe ulcerative colitis
5. Cyclosporin in ulcerative colitis
6. Cyclosporin monotherapy is effective in the treatment of severe ulcerative colitis
7. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis: A randomized controlled trial
8. Glucocorticoids
9. Immunomodulatory therapy in inflammatory bowel disease
10. Cyclosporine therapy for gastrointestinal disease
11. Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis
12. Cyclosporin for severe ulcerative colitis: A user's guide
13. An evaluation of utility measurement in Crohn's disease
14. Quality of life of patients with ulcerative colitis preoperatively and postoperatively
15. A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin
16. Steroid-unresponsive acute attacks of inflammatory bowel disease: Immunomodulation by tacrolimus (FK506)
17. Oral tacrolimus treatment of severe colitis in children
18. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: A 12-month pilot study
19. Mycophenolate mofetil: Lack of efficacy in chronic active inflammatory bowel disease
20. Chimeric monoclonal anti-tumor necrosis factor antibody (cA2) in the treatment of severe, steroid-refractory ulcerative colitis (UC)
21. Infliximab is an effective therapeutic agent for ulcerative colitis
22. Treatment of ulcerative colitis with an engineered human anti-TNF antibody CDP571
23. 7 antibody in ulcerative colitis (UC)